For a disease that has led the field of molecular biology, it is surprising perhaps that so few biomarkers have been identified that can predict a person’s risk of developing cancer. Researchers are now looking [more]
“In the history of cancer research, there has always been tension between those who want to treat cancer and those who think we should prevent it,” writes the pioneering medical oncologist and former head of the [more]
Almost four in ten serious adverse drug reactions now listed in the labels of 12 targeted cancer therapies were not mentioned in the studies that led to their approval. Half the serious reactions that were [more]
Thrombosis is the second most common preventable cause of death in patients with cancer, so oncologists need to know how to identify who is at risk, and strategies for prevention and treatment. This overview presents [more]